CN Patent

CN111670189A — 对rsv具有活性的环烷基取代的吡唑并嘧啶

Assigned to Janssen Sciences Ireland ULC · Expires 2020-09-15 · 6y expired

What this patent protects

本发明涉及具有抗病毒活性的、特别是对呼吸道合胞病毒(RSV)的复制具有抑制活性的具有式(I)的化合物。本发明进一步涉及包含这些化合物的药物组合物以及用于在呼吸道合胞病毒感染的治疗中使用的这些化合物。(式I)

USPTO Abstract

本发明涉及具有抗病毒活性的、特别是对呼吸道合胞病毒(RSV)的复制具有抑制活性的具有式(I)的化合物。本发明进一步涉及包含这些化合物的药物组合物以及用于在呼吸道合胞病毒感染的治疗中使用的这些化合物。(式I)

Drugs covered by this patent

Patent Metadata

Patent number
CN111670189A
Jurisdiction
CN
Classification
—
Expires
2020-09-15
Drug substance claim
No
Drug product claim
No
Assignee
Janssen Sciences Ireland ULC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.